Moderators: Marilyn Huang, MD, Stephanie Gaillard, MD, and Evelyn Cantillo, MD

Presentations:

• Tisotumab Vedotin (Leslie Randall, MD)
• Mirvetuximab Soravtansine (Ursula Matulonis, MD)
• Upifitamab Rilsodotin (Debra Richardson, MD)
• Eye Toxicities (Meghan Berkenstock, MD)